Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of BriaCell Therapeutics Corp. from Q2 2022 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
BriaCell Therapeutics Corp. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q2 2022 to Q2 2025.
- BriaCell Therapeutics Corp. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Jul 2025 was $17,334,046.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)